FGFR inhibitor Derazantinib, Purity ≥98%

Cat. No.: X24-06-ZQ079

FGFR inhibitor Derazantinib, Purity ≥98%

Synonym: 1234356-69-4; FGFR inhibitor; ARQ087; ARQ 087

  • CAS Number: 1234356-69-4
  • Compound CID: 46834118
Product Size
2 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Derazantinib, soluble in DMSO and insoluble in ethanol and water, is a protein tyrosine kinase inhibitor that has shown potent biochemical activity against FGFR. It targets FGFR1, FGFR2, and FGFR3.
Molecular Weight
468.57
Molecular Formula
C29H29FN4O
Targets
FGFR1: 4.5 nM; FGFR2: 1.8 nM; FGFR3: 4.5 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 80 mg/mL (170.73 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Derazantinib is applied in the study of FGFR as a selective inhibitor, offering potential therapeutic insights in oncology research, focusing on FGFR-driven cancers.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0